Physician profile
Devyani Lal
NPI 1689834475
$8,163.56
in general payments reported to CMS, 2019-2025
9 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $687 · 2020: $248 · 2021: $6,500 · 2022: $133 · 2023: $159 · 2024: $154 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $6,541.73 | 2021-2025 | Nucala |
| Intersect Ent, INC. | $424.42 | 2019-2020 | |
| Acclarent, INC | $362.17 | 2019-2023 | Trudi Nav Cable |
| Medtronic USA, INC. | $248.92 | 2019-2020 | |
| Stryker Corporation | $187.41 | 2019-2025 | Xpress Loprofile |
| Integra Lifesciences Corporation | $154.15 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Inspire Medical Systems, INC. | $97.22 | 2025 | Inspire |
| Medtronic, INC. | $95.93 | 2025 | Fusion |
| 3-D Matrix, INC. | $51.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devyani Lal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.